Cargando…
Lysophosphatidic acid enhances survival of human CD34(+) cells in ischemic conditions
Several clinical trials are exploring therapeutic effect of human CD34(+) cells in ischemic diseases, including myocardial infarction. Unfortunately, most of the cells die few days after delivery. Herein we show that lysophosphatidic acid (LPA)-treated human umbilical cord blood-derived CD34(+) cell...
Autores principales: | Kostic, Ivana, Fidalgo-Carvalho, Isabel, Aday, Sezin, Vazão, Helena, Carvalheiro, Tiago, Grãos, Mário, Duarte, António, Cardoso, Carla, Gonçalves, Lino, Carvalho, Lina, Paiva, Artur, Ferreira, Lino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639756/ https://www.ncbi.nlm.nih.gov/pubmed/26553339 http://dx.doi.org/10.1038/srep16406 |
Ejemplares similares
-
Towards the Maturation and Characterization of Smooth Muscle Cells Derived from Human Embryonic Stem Cells
por: Vazão, Helena, et al.
Publicado: (2011) -
Role of monocytes and dendritic cells in cardiac reverse remodelling after cardiac resynchronization therapy
por: Martins, Sílvia, et al.
Publicado: (2023) -
Reduced numbers of regulatory T cells in chronic heart failure seems not to be restored by cardiac resynchronization therapy
por: Martins, Sílvia, et al.
Publicado: (2023) -
Synthetic microparticles conjugated with VEGF(165) improve the survival of endothelial progenitor cells via microRNA-17 inhibition
por: Aday, Sezin, et al.
Publicado: (2017) -
Holiday Heart Syndrome Revisited after 34 Years
por: Tonelo, David, et al.
Publicado: (2013)